Viapharma Hurtownia Farmaceutyczna sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-08-25
Share capital
5,000,000.00 PLN
Registered address
ul. Krzemieniecka 60A, 54-613 Wrocław, Poland
Electronic delivery address
AE:PL-18743-37384-JSABB-27

Financials

Revenue history (in m)

Financial insight

  • The statement flags a going concern risk. Na dzień 31 grudnia 2025 r. skumulowane straty wyniosły 52.007.139,64 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz połowę kapitału zakładowego o kwotę 52.004.639,64 zł. Stosownie do wymogów art. 233 ustawy z dnia 7.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18) Nadzwyczajne Zgromadzenie Wspólników w dniu 06.03.2026 r. podjęło uchwałę o kontynuowaniu działalności firmy. Spółka posiada zapewniony dostęp do finansowania w ramach grupowego systemu cash pool oraz w razie potrzeby, możliwość pozyskania środków w formie pożyczek wewnątrzgrupowych. W dniu 15.06.2026. otrzymała, pośrednio poprzez swojego udziałowca Spółkę DR.MAX Sp. z o.o., list wsparcia, w którym właściciel, Pharmax Holdings Limited, potwierdza wolę wsparcia finansowego Spółki.

From the notes

Current income tax (CIT due)$0

Filing timeliness

3 of 4 financial statements were filed late (the longest delay 44 days for 2022). 1 of 4 audited by a statutory auditor.

  • 202506/07/2026
  • 202417/07/2025
  • 202324/07/2024
  • 202228/08/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods32 / 1,136
Top 2.8%
Division · Wholesale trade147 / 20,037
Top <1%
City · Wrocław37 / 13,650
Top <1%
Voivodeship · Dolnośląskie82 / 23,831
Top <1%
Country · Poland1,062 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 205.49mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD -8.14mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 210.01mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 109.79mMedianUSD 610.11kAverageUSD 11.92m

Authorized Representatives

Edyta Anna Goryszewska-Szumska age 54 – Management Board Member
Branislav Chmela – President of the Management Board
Paweł Stanisław Jakubowski age 36 – Attorney-in-fact (joint)
Marcin Łojewski age 46 – Attorney-in-fact (sole)

Manner of representation

If the management board is a multi-member management board, joint action of two members of the management board, or one member of the management board together with a commercial proxy, is required to make declarations on behalf of the company. If the management board is a one-person management board, the President of the Management Board represents the company independently.

Ownership

OwnerSharesShare valueStake
100,000$1,350,621.29100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 3M

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Pfizer Trading Polska sp. z o.o.
Asclepios S.A.
Medi&More sp. z o.o.
Novo S.A.
Bialmed sp. z o.o.
Medivet S.A.
Servier Polska Services sp. z o.o.
Przedsiębiorstwo Zaopatrzenia Aptek Multi Pharme S.A.
Lubfarm S.A.
Nettle S.A.

Change history

DateEvent
2026-10-09Share capital increase
2026-04-21PKD change
2023-05-15Name change
2021-08-25Entered in the register

FAQ

Last updated: 2026-10-09